Replicel

[DepressedByHairLoss]

The intial trial was an "overdosing" trial. David Hall said that they injected millions of cells into the testing location on the temples to prove whether the treatment worked at all and if it was safe. If it doesn't work, it won't be because they did not inject a high enough number of cells!

I went back and re-listened to the first interview done by Spencer and I picked up something I missed the first time around. Back in September 2011, it was anticipated that during phase II, they would be dosing down in 3 increment levels down, to determine the number of cells that would need to be injected to provide an effective treatement, and possibly provide a range of hair regrowth dependent upon the number of cells injected.

Very interesting post; thanks for posting it. And good news too that they're "overdosing" in this trial. To me, this makes it seem like they're serious about releasing their hair growth treatment/cure sooner rather than later.

[wherediditgo]

Does anybody think that replicel or any other company out right now has the ability to provide a CURE that would give back all your hair or is that still to come? I realize that the least everyone is hoping for is a treatment that is significantly better than anything we have right now.

[lpenergy]

So, Replicel just announces the closing of a private placement to provide working capital, which will provide an additional $1.3 Million for funding. The shares were priced at $1.50, with warrants at $2.50/share that can be used in the next 24 months.

Quick Thoughts:

1) Working capital needs imply the need for capital for future use.

2) Whomever the private placement purchaser was, this investor or group of investors seems believe that there is some value in the warrants at $2.50/share, which is a good thing.

3) The $1.50/share purchase price is obviously at a discount to market, so I am not sure what will happen to the share price tomorrow.

4) I remember reading somewhere that they were indending on additional funding prior to going to phase II, so there is not much of a surprise here.

http://www.marketwire.com/press-rele...cf-1638190.htm

[NotBelievingIt]

So, Replicel just announces the closing of a private placement to provide working capital, which will provide an additional $1.3 Million for funding. The shares were priced at $1.50, with warrants at $2.50/share that can be used in the next 24 months.

Quick Thoughts:

1) Working capital needs imply the need for capital for future use.

2) Whomever the private placement purchaser was, this investor or group of investors seems believe that there is some value in the warrants at $2.50/share, which is a good thing.

3) The $1.50/share purchase price is obviously at a discount to market, so I am not sure what will happen to the share price tomorrow.

4) I remember reading somewhere that they were indending on additional funding prior to going to phase II, so there is not much of a surprise here.

http://www.marketwire.com/press-rele...cf-1638190.htm

Yesterday it already dropped abnormally high to the market even for being low volume, this was likely the dilution.

I agree too it is a good sign if the warrants were for $2.50/share that means they fully expect a higher stock price then that by the time the warrants are ended or available to be swapped.